Back to mobile site

More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 76.45 +0.03 (0.04%)
Prev. Close $76.42  
Open$76.81 
52 Wk High$ 
52 Wk Low$ 
Day High$80.27 
Day Low$74.43 
P/E N/A  
EPS$ 
Volume1,441,847 

Friends, Peers and Foes (?): TOI, ALNY, ARGX, BBIO, BIIB (more...)

Jun 10, 2026 04:10 PM Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
Jun 10, 2026 03:52 PM Dianthus Therapeutics (DNTH) PT Raised to $132 at Jefferies
Jun 10, 2026 01:37 PM TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity'
Jun 10, 2026 01:01 PM Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
Jun 10, 2026 10:40 AM Wolfe Research on Dianthus Therapeutics (DNTH): 'Not a negative but also not a strong positive'
Jun 10, 2026 10:38 AM Truist on Dianthus Therapeutics (DNTH) Amid Extreme Selloff: 'we believe the readthrough to DNTH should be limited'
Jun 10, 2026 07:21 AM Dianthus Therapeutics (DNTH) Reiterated at Buy by Stifel
Jun 2, 2026 07:00 PM Form 4 Dianthus Therapeutics, For: Jun 01 Filed by: Randhawa Simrat
Jun 2, 2026 04:01 PM Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 1, 2026 04:14 PM Form 144 Dianthus Therapeutics, Filed by: Randhawa Simrat
View All Articles

Entities mentioned with DNTH

View All Entities